EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • November 9th, 2018 • Ziopharm Oncology Inc • Pharmaceutical preparations • New York
Contract Type FiledNovember 9th, 2018 Company Industry JurisdictionThis EXCLUSIVE LICENSE AGREEMENT (the “Agreement”) is entered into as of October 5, 2018 (the “Effective Date”) by and between ZIOPHARM ONCOLOGY, INC., a Delaware corporation, with its principal place of business at 1180 Avenue of the Americas, 19th Floor, New York, NY 10036 (“Ziopharm”), and PRECIGEN, INC., a Delaware corporation, with its principal place of business at 20358 Seneca Meadows Parkway, Germantown, MD 20876 (“Precigen”), a wholly owned subsidiary of Intrexon Corporation, a Virginia corporation, with its principal place of business at 20374 Seneca Meadows Parkway, Germantown, MD 20876 (“Intrexon”). Ziopharm and Precigen are sometimes referred to herein individually as a “Party” and collectively as the “Parties”. Intrexon is a party to: the Recitals; Section 2.2, Section 3.4, Article 13 and Section 14.13 of this Agreement.